Sema4 (NASDAQ:SMFR – Get Rating) and DCC (OTCMKTS:DCCPF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations. Analyst Recommendations This is a summary of recent ratings for Sema4 and […]
Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) insider Eric Schadt acquired 100,000 shares of the company’s stock in a transaction dated Friday, May 20th. The shares were bought at an average price of $1.92 per share, for a total transaction of $192,000.00. Following the purchase, the insider now owns 243,380 shares in the company, valued […]
Sema4 (NASDAQ:SMFR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and […]
Sema4 (NASDAQ:SMFR – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic […]
Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) insider Kareem Saad sold 6,269 shares of the company’s stock in a transaction dated Wednesday, April 20th. The shares were sold at an average price of $2.49, for a total value of $15,609.81. Following the sale, the insider now owns 64,289 shares in the company, valued at $160,079.61. […]